Limited Competition for Fragile X Research Center Revision Applications (P30)

The summary for the Limited Competition for Fragile X Research Center Revision Applications (P30) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Limited Competition for Fragile X Research Center Revision Applications (P30)
	CFDA Number:	93.865
	CFDA Description:	Child Health and Human Development Extramural Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HD-07-013
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Mar 23, 2007
	Creation Date:	Mar 23, 2007
	Original Closing Date for Applications:	May 26, 2007
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jun 25, 2007
	Expected Number of Awards:	3
	Estimated Total Program Funding:	$4,000,000
	Federal Grant Award Ceiling:	$1,330,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Any currently funded NICHD MRDDRC with scientific personnel and institutional resources capable of providing a strong research base in Fragile X is eligible. Individual MRDDRCs may submit one application, but a given application may involve multiple sites, including other MRDDRCs and partners that may be domestic or foreign non-profit and for-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State or local government; and eligible agencies of the Federal government.
Grant Description: - Purpose. The original RFA for Fragile X syndrome Research Centers was developed in response to the Children's Health Act of 2000 (H. R. 4365) Section 452E and funded three successful applications. It is the purpose of this RFA to maintain the momentum of discovery and further develop research relevant to Fragile X syndrome and associated disorders. The Fragile X Research Centers are intended to stimulate the formation of multidisciplinary, multi-institutional teams with a goal of facilitating the translation of basic research findings related to Fragile X syndrome from bench-to-bedside-to-community. -Mechanism of Support. This limited competition RFA will use the NIH Center Core Grant (P30) funding mechanism. Awards will be made for Centers-within-Centers as revisions (formerly called supplements) to existing Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Core Grants (P30). - Funds Available and Anticipated Number of Awards. The NICHD anticipates making up to three awards in response to this RFA. The NICHD intends to commit up to $4 million total costs annually for this program.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-07-013.html http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-07-013.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Biomedical/Biobehavioral Research Administration Development (BRAD) Award [G11]; • Rehabilitation Research Career Development Programs (K12); • Pediatric Scientist Development Program (PSDP) [K12]; • Translational Research in Pediatric and Obstetric Pharmacology (R21); • Translational Research in Pediatric and Obstetric Pharmacology (R01); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Stud...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Preclinical Stud...; • REPRODUCTIVE GENETICS AND EPIGENETICS; • DEVELOPMENTAL MECHANISMS OF HUMAN STRUCTURAL BIRTH DEFECTS; • ENDOMETRIAL CELL FUNCTION